FIA
RVMD icon

FNY Investment Advisers’s Revolution Medicines RVMD Stock Holding History

FNY Investment Advisers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
+10
New +$1.46K ﹤0.01% 811

Other funds holding RVMD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

FNY Investment Advisers's RVMD Position: Q2 2026 in Review

FNY Investment Advisers sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 1,310 shares — an estimated $191K sold.

FNY Investment Advisers first reported a position in RVMD in Q3 2025 and held it in 2 quarters. The position peaked at $127K in Q1 2026. 263 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • FNY Investment Advisers reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 1,310 Revolution Medicines shares in Q2 2026, an estimated $191K.
  • FNY Investment Advisers first reported a position in Revolution Medicines in Q3 2025 and held it in 2 quarters.
  • FNY Investment Advisers's Revolution Medicines position peaked at $127K in Q1 2026.
  • 263 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.